Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
201
-
Total 13F shares, excl. options
-
18.3M
-
Shares change
-
+165K
-
Total reported value, excl. options
-
$2.19B
-
Value change
-
+$17.3M
-
Put/Call ratio
-
0.13
-
Number of buys
-
107
-
Number of sells
-
-79
-
Price
-
$119.71
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q2 2014
225 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q2 2014.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 201 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.3M shares
.
Largest 10 shareholders include ATLANTA CAPITAL MANAGEMENT CO L L C (1.84M shares), VANGUARD GROUP INC (1.17M shares), ARIEL INVESTMENTS, LLC (983K shares), LEVIN CAPITAL STRATEGIES, L.P. (954K shares), Champlain Investment Partners, LLC (826K shares), ROYCE & ASSOCIATES LLC (813K shares), WELLS FARGO & COMPANY/MN (760K shares), BlackRock Fund Advisors (621K shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (586K shares), and BlackRock Institutional Trust Company, N.A. (575K shares).
This table shows the top 201 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.